FTC sues major pharmacy benefit managers around insulin selling prices The company introduced motion from Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record cost of life-preserving insulin prescription drugs. Exactly where are all the nurses? Hospitals, advocates disagree on crisis Hospitals https://busch-light-peach-nutriti27261.izrablog.com/31184827/healthcare-news-an-overview